Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, ResMed Inc. (RMD) trades at a EV/Sales of 6.0×. Over the past ten years it has ranged from 3.9× (September 2015) to 13.6× (September 2021); the current reading is higher than 34% of that period. That is above the Medical Instruments & Supplies industry median of 2.9× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 4.8× (33.40%)
FY2025 7.2× 21.53%
FY2024 6.0× (24.30%)
FY2023 7.9× (9.39%)
FY2022 8.7× (23.15%)
FY2021 11.3× 17.75%
FY2020 9.6× 33.06%
FY2019 7.2× 13.44%
FY2018 6.4× 16.80%
FY2017 5.5× 11.24%

Quarterly newest first

Period EV/Sales Change
Jun 2026 4.8× (14.78%)
Mar 2026 5.7× (10.37%)
Dec 2025 6.3× (14.89%)
Sep 2025 7.4× 2.45%
42 more quarters

Against its own ten years

Low 3.9× High 13.6×
Ten-year median 6.8×
Current reading's percentile 28

EV/Sales against peers

Company EV/Sales
MDLN Medline Inc. compare 1.4×
BAX Baxter International Inc. compare 1.8×
SOLV Solventum Corporation compare 2.4×
BDX Becton, Dickinson and Company compare 2.9×
COO The Cooper Companies, Inc. compare 3.2×
ALC Alcon compare 3.3×
RMD ResMed Inc. 6.0×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.3×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RMD